Although not statistically significant, this positive difference was found to be reverted in G3-grade patients: notably, OS is lower in a high-NGB-expressing tumor (red line) when compared to the low-NGB-expressing patients after three years (gray line). The gene discussed is NGB; the disease is neoplasm.